University Medical Center Hamburg, Germany, India
Author Profile
Early Academic Pursuits 🎓✨
Dr. Praveer Sihota’s journey into the fascinating realm of biomedical engineering began with a robust academic foundation. Completing his Bachelor of Engineering in Biomedical Engineering from Rajiv Gandhi Technical University, Bhopal (2006-2010), he achieved a commendable score of 73.5%. Building on this, he pursued a Master of Technology in Biomedical Engineering at MIT, Manipal University, Karnataka (2011-2013), earning an impressive CGPA of 8.14/10.
His academic progression culminated in a Ph.D. in Biomedical Engineering from the prestigious Indian Institute of Technology Ropar (2015-2021). His doctoral research not only expanded the boundaries of knowledge in bone characterization but also earned him the Best PhD Thesis of the Year 2021, a testament to his groundbreaking work. 📜🏆
Professional Endeavors 💼🔬
Dr. Sihota’s professional journey reflects his dedication to exploring biomedical engineering and bone health. Early in his career, he honed his skills as an M.Tech Trainee in Bioinstrumentation at CSIR-CSIO Chandigarh (2012-2013). He then advanced to roles such as Research Fellow in Biostatistics at IIT Mandi (2013-2014) and in Endocrinology at PGIMER Chandigarh (2015).
Notably, as a Project Assistant at IIT Ropar (2021), he delved into bone mechanical testing. Currently, Dr. Sihota holds the prestigious Alexander von Humboldt Fellowship as a Post-doctoral Research Fellow in the Department of Osteology and Biomechanics (IOBM), University Medical Center Hamburg-Eppendorf, Germany (2022-2025). His work focuses on the multi-scale assessment of bone quality, furthering insights into metabolic bone diseases. 🌍🔍
Contributions and Research Focus 🧬🛠️
Dr. Sihota’s research delves into the multiscale characterization of bone, emphasizing metabolic disorders like type 2 diabetes, obesity, and osteoporosis. His studies on the effects of advanced glycation end products and glucocorticoids reveal their impact on bone material and mechanical properties, mineralization, collagen quality, and skeletal fragility.
By leveraging clinical cohorts and animal models, Dr. Sihota investigates the underlying mechanisms of pathological bone changes, offering critical insights into fracture risks. His work stands as a beacon for developing diagnostic tools and treatments to combat fragility fractures, enhancing the quality of life for individuals with metabolic bone diseases. 🩺🦵
Accolades and Recognition 🌟🏅
Dr. Sihota’s exemplary contributions have garnered accolades, with his Best PhD Thesis of the Year 2021 highlighting his innovative approach and dedication. Being selected as an Alexander von Humboldt Fellow is another significant milestone, reflecting his status as a leading researcher in his field.
Impact and Influence 🌍📈
Dr. Sihota’s work has left a profound impact on both academic and clinical realms. By integrating engineering principles with medical science, he addresses critical challenges in bone health. His research findings have implications for clinicians, researchers, and healthcare policymakers, shaping strategies to prevent and manage bone fragility.
Legacy and Future Contributions 🔮🚀
Dr. Sihota’s legacy is rooted in his commitment to advancing biomedical engineering. Looking ahead, he aims to expand the frontiers of bone health research, exploring new diagnostic tools and innovative treatments for metabolic bone diseases. His vision encompasses fostering interdisciplinary collaboration and mentoring the next generation of researchers.
With a career characterized by excellence, innovation, and compassion, Dr. Praveer Sihota continues to inspire and contribute significantly to the global scientific community. His journey exemplifies the power of perseverance and intellectual curiosity, paving the way for a healthier future. 🌟👨🔬
A total of 315 citations for his publications, demonstrating the impact and recognition of his research within the academic community.
- Citations 315
- h-index 22
- i10-index 10
Notable Publications
- Bone-seeking tumor cells alter bone material quality parameters on the nanoscale in mice
- Authors: Krug, J., Plumeyer, C., Davydok, A., Fiedler, I.A.K., Jähn-Rickert, K.
- Journal: Biomaterials Advances
- Year: 2025.
- Osteomodulin deficiency in mice causes a specific reduction of transversal cortical bone size
- Authors: Zhao, W., von Kroge, S., Jadzic, J., Schinke, T., Yorgan, T.A.
- Journal: Journal of Bone and Mineral Research
- Year: 2024.
- Lower microhardness along with less heterogeneous mineralization in the femoral neck of individuals with type 2 diabetes mellitus indicates higher fracture risk
- Authors: Cirovic, A., Schmidt, F.N., Vujacic, M., Busse, B., Milovanovic, P.
- Journal: JBMR Plus
- Year: 2024.
- Type 2 diabetes alters the viscoelastic behavior and macromolecular composition of vertebra
- Authors: Mehta, D., Sihota, P., Tikoo, K., Kumar, S., Kumar, N.
- Journal: Bone Reports
- Year: 2023.
- The multiscale characterization and constitutive modeling of healthy and type 2 diabetes mellitus Sprague Dawley rat skin
- Authors: Dwivedi, K.K., Lakhani, P., Sihota, P., Kumar, S., Kumar, N.
- Journal: Acta Biomaterialia
- Year: 2023.